Lunit INSIGHT DBT (3D)

What it does

Lunit INSIGHT DBT (3D) takes digital breast tomosynthesis (3D mammography) exams as input and returns AI analysis of the image stack. It scores suspicious lesions from 0 to 100 for likelihood of malignancy, marks their location with heatmaps or contours, and classifies them as masses (including asymmetries and distortions) or calcifications. It also marks the best slice for each lesion on the navigation bar and can show scores for the current exam and up to two prior exams.

Radiologists use it during image review to jump to key slices rather than scrolling the full stack, and it is built to integrate with PACS and image viewers. The page says it supports single and double-reading workflows. A distinctive feature is that the current-exam AI score is not adjusted using prior exams; prior scores are shown separately for comparison over time.

It suits breast radiology teams and radiologists reading DBT exams, particularly screening programs. The page says the product is not available for sale or distribution in all countries, and it directs buyers to 'Speak with a Specialist' rather than publishing pricing or self-serve access. Limitations stated on the page include that it does not learn in real time, that it targets malignant rather than benign findings, and that the score measures likelihood of cancer, not severity or prognosis.

What it can do

• Assigns each suspicious lesion an abnormality score from 0 to 100 indicating likelihood of malignancy
• Marks lesion location using heatmaps or contours
• Classifies lesions as masses (including asymmetries and distortions) or calcifications
• Automatically marks the best slice for lesion visualization on the navigation bar
• Shows scores for the current exam and up to two prior exams for comparison

Works with

• PACS
• Image viewers (page states built for seamless integration; specific vendors not named)

Before you choose

• Pricing and licensing are not published; availability depends on country and sales contact.
• The AI score reflects likelihood of malignancy, not severity, prognosis, or treatment outcome, and the scale is not linear.
• The AI does not learn in real time, and images from commercial sites are used only for processing, not retraining.

Listed under

• Healthcare

Get started

The page directs interested buyers to contact a specialist; an interactive demo is also offered.

1. Confirm the product is available in your country, since the page says it is not available for sale or distribution in all countries.
2. Contact a Lunit specialist via the 'Speak with a Specialist' link to discuss integration with your PACS and viewer.
3. Optionally try the interactive demo on the product page before committing to a deployment.

No price, plan, or billing basis is stated for INSIGHT DBT; buyers should confirm cost and licensing through a Lunit specialist.

We couldn’t find published prices for Lunit INSIGHT DBT (3D).

Sources for this overview

Product pages, documentation, and pricing checked 29 Oct 2026. Each source supports part of the overview; availability and prices can change.

• AI-Assisted Mammography for 3D Detection | Lunit ↗www.lunit.io
• Early Detection & Precision Oncology Medical AI Software | Lunit ↗www.lunit.io
• Product Documentation ↗www.lunit.io

Company website

lunit.io: product, pricing and policy pages

Social accounts

Accounts the company links, and its posts on X

Human review

Checked by a person

knowledge_base

manual_review

Last checked 29 Oct 2026. Every field keeps its source and date; unknown means we couldn’t confirm it.